Early research (Phase 1)Active Not RecruitingNCT07737717
What this trial is testing
Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469 Vaccine to Prevent Ebola-Bundibugyo Virus Disease in Healthy Adult Participants
Who this might be right for
Ebola-Bundibugyo Virus Disease (Ebola-BDBV)
ModernaTX, Inc. 84